Non-parametric N [Power / Sample Size]

posted by Helmut Homepage – Vienna, Austria, 2022-09-06 19:02 (620 d 19:23 ago) – Posting: # 23274
Views: 2,267

Hi Alex,

❝ So we would calculate our N based on a non-parametric test for T-max differences (I have heard some epidemologists saying its ok to calculate with T-Test and increase like 15%)

That’s black magick. Why 15%?

❝ Kind of related, I guess no concern exists about the almost sure increase in Cmax if it doesnt go beyond the therapeutic range inst it?

No idea. In the EMA’s bracketing approach you perform a Non-Superiority test with an upper margin of 1.25. All of this stuff (including BE) is not related to the therapeutic range at all.

❝ Not possible to calculate N for Tmax but to perform certain simulations with some parameters.

Even then it’s not an easy job.

❝ So better to run a pilot without and seein what comes?


❝ if you are right Tmax will come sooner (with a higher Cmax).

Likely. But as I wrote before: Under the premise of no saturable pre-systemic metabolism.

❝ Would it support a SmPC change?

No idea. Once you have the result of a pilot, consider a scientific advice. Sweden?

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
 Admin contact
23,029 posts in 4,834 threads, 1,644 registered users;
30 visitors (0 registered, 30 guests [including 7 identified bots]).
Forum time: 14:25 CEST (Europe/Vienna)

We must be careful not to confuse data with the abstractions
we use to analyze them.    William James

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz